INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 64 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $35,000 | +40.0% | 13,000 | 0.0% | 0.01% | +33.3% |
| Q2 2018 | $25,000 | -7.4% | 13,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $27,000 | +3.8% | 13,000 | 0.0% | 0.01% | -10.0% |
| Q4 2017 | $26,000 | +52.9% | 13,000 | 0.0% | 0.01% | +42.9% |
| Q3 2017 | $17,000 | -15.0% | 13,000 | 0.0% | 0.01% | -22.2% |
| Q2 2017 | $20,000 | -52.4% | 13,000 | 0.0% | 0.01% | -57.1% |
| Q1 2017 | $42,000 | – | 13,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $819,180 | 0.18% |
| BVF INC/IL | 6,353,645 | $3,526,273 | 0.15% |
| Gratus Capital, LLC | 1,323,598 | $734,600 | 0.06% |
| Bleichroeder LP | 250,000 | $138,750 | 0.03% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $302,757 | 0.01% |
| Callan Capital, LLC | 158,500 | $87,968 | 0.01% |
| Polar Capital Holdings Plc | 2,071,242 | $1,149,539 | 0.01% |
| Virtu Financial LLC | 66,537 | $37 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $138,195 | 0.00% |
| Pacific Sage Partners, LLC | 17,500 | $9,713 | 0.00% |